Indications for treatment in chronic HCV infection
Journal Title: Annals of Hepatology - Year 2010, Vol 9, Issue 0
Abstract
HCV Infection is a global burden disease and it is related to the development of progressive liver fibrosis, cirrhosis and hepatocellular carcinoma. At least 80% of the persons that have an acute infection evolve to chronicity. This event affects the patient and their contacts for the risk of acquiring the infection. Once chronic HCV is present some factors accelerate progression: older age, obesity, alcohol consumption, etc. Severity of fibrosis is one of the most important factors to be analyzed before deciding to treat a patient. Pegylated interferon and ribavirin is the .standard of care. for this disease, however, it has many side effects, some of them life threatening. That is the reason why this treatment must be indicated in the right moment in the right patient. A complete medical evaluation must be done previously to initiate treatment. Other concurrent problems must be ruled out or treated. Decompensated cirrhosis, autoimmune diseases or other uncontrolled disease are contraindication to HCV treatment. Previous failure to treatment for HCV must be analyzed to identify the reasons for that event and consider retreatment. Cryoglobulinemia and membranoproliferative glomerulonephritis are indications for treatment independent from the severity of liver disease.
Authors and Affiliations
Milagros Dávalos Moscol
Keywords
Related Articles
- EP ID EP77963
- DOI -
- Views 125
- Downloads 0
Resistance-associated polymorphisms in Dutch hepatitis C genotype 1a patients with and without HIV infection
Background and aim. Resistance-associated variants (RAVs) on the NS3 region of the hepatitis C virus (HCV) may be relevant for antiviral therapy, but data in human immunodeficiency virus (HIV) coinfected patients are sc...
Renal and circulatory effects of large volume plasma expansion in patients with hepatorenal syndrome type 1
Introduction. Hepatorenal syndrome type I (HRS I) may be a consequence of circulatory dysfunction in cirrhotic patients with portal hypertension. This uncontrolled interventional pilot study examines the hemodynamic and...
Nonalcoholic fatty liver disease and polycystic ovary syndrome
Treatment regimens for non-alcoholic fatty liver disease
With the growing epidemic of obesity and diabetes, more attention has been placed on metabolic syndrome and its associated hepatic manifestation, non-alcoholic fatty liver disease (NAFLD). Within the spectrum of clinico...
Mexican-native human echinococcosis: Case report of an underestimated disease
Mexico is considered a virtually free region of cystic echinococcosis. Almost all case reports within the country involve immigrants or traveling patients. This manuscript presents a Mexican-native human echinococcosis t...